Text Size

Nasal Provocation Testing in Occupational Rhinitis (NPT)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Haukeland University Hospital
ClinicalTrials.gov Identifier:
NCT01436851
First received: August 16, 2011
Last updated: May 10, 2012
Last verified: May 2012
History of Changes
  Purpose

In a previous study the investigators found that many bakery workers were sensitized to storage mites, and many had rhinitis symptoms. The role of storage mites as an occupational allergen with clinical relevance has been questioned, and the investigators wanted to investigate whether a nasal provocation with a storage mite extract would trigger symptoms and objective signs of rhinitis in bakery workers and a control group.


Condition Intervention
Allergic Rhinitis (Disorder)
 Biological: Storage mite allergen extracts

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Diagnostic
Official Title: Nasal Provocation Testing With Nasal Lavage in Allergic and Non-allergic Occupational Rhinitis

Further study details as provided by Haukeland University Hospital:

Primary Outcome Measures:
  • Measurements of indices of inflammation in nasal lavage after specific nasal provocation with storage mite allergen [ Time Frame: Change from baseline to 10 minutes after nasal provocation ] [ Designated as safety issue: No ]
    Indices of inflammation (alfa2-macroglobulin, eosinophil cationic protein) in nasal lavage after specific nasal provocation with storage mite allergen (Acarus Siro or Lepidoglyphus Destructor) twice, the second provocation with doubled allergen concentration


Secondary Outcome Measures:
  • Rhinitis symptoms after specific nasal provocation with storage mite allergen glyphus Destructor) [ Time Frame: Change from baseline to 10 minutes after provocation ] [ Designated as safety issue: No ]
    Rhinitis symptoms measured by symptoms score and visual analog scale, before and after specific nasal provocation with storage mite allergen (Acarus Siro, Lepidoglyphus Destructor) twice, the second time with doubled concentration of allergen

  • Reduction in nasal patency measured by peak nasal inspiratory flow meter after specific nasal provocation with storage mite allergen [ Time Frame: Change from baseline to 10 minutes after provocation ] [ Designated as safety issue: No ]
    Reduction in nasal patency measured by peak nasal inspiratory flow meter before and after specific nasal provocation with storage mite allergen (Acarus Siro, Lepidoglyphus Destructor) twice, the second time with doubled concentration of allergen

  • Objective signs of rhinitis assessed by rhinoscopy after specific nasal provocation with storage mite allergen [ Time Frame: Change from baseline to 10 minutes after provocation ] [ Designated as safety issue: No ]
    Objective signs of rhinitis assessed by anterior rhinoscopy, and notified as a clinical score before and after specific nasal provocation with storage mite allergen (Acarus Siro, Lepidoglyphus Destructor) twice, second time with the doubled allergen concentration


Estimated Enrollment: 30
Study Start Date: August 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Storage mite allergen
Provocation in the nose either with an allergen extract of a storage mite (A. Siro or L. Destructor) and placebo (physiologic salt water)
 Biological: Storage mite allergen extracts
Nasal provocation with increasing doses of storage mite allergen extracts
Other Names:
  • Acarus Siro
  • Lepidoglyphus Destructor

Detailed Description:

The investigations include allergy testing with skin prick testing, and measuring of specific IgE in sera, answering a questionnaire, and symptom scoring before and after provocations. The participants will be investigated one day with a placebo, and another day with the allergen extract of either Acarus Siro or Lepidoglyphus Destructor. As a measurement of nasal patency we use the nasal peak inspiratory flow meter, but also clinical scoring of nasal secretion and blockage. Indices of inflammation (ECP and alfa-Macroglobulin) will be monitored in nasal lavage.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • bakery workers
  • > 18 years
  • sensitized to a storage mite (A.Siro or L. Destructor)

Exclusion Criteria:

  • pregnant or breast-feeding
  • infection in upper or lower airways the last month
  • nasal polyposis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01436851

Locations
Norway
Dept. of Occupational Medicine, Haukeland University Hospital
Bergen, Norway, 5021
Sponsors and Collaborators
Haukeland University Hospital
Investigators
Principal Investigator: Torgeir Storaas, MD PhD Haukeland University Hospital
  More Information

No publications provided

Responsible Party: Haukeland University Hospital
ClinicalTrials.gov Identifier: NCT01436851     History of Changes
Other Study ID Numbers: 2009/265
Study First Received: August 16, 2011
Last Updated: May 10, 2012
Health Authority: Norway: Directorate of Health

Keywords provided by Haukeland University Hospital:
rhinitis
allergy
occupational
storage mites
 nasal lavage
challenge test
ECP
alfa2Macroglobuline

Additional relevant MeSH terms:
Rhinitis
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on May 19, 2013